NDC codes

FDA NDC Directory
Product NDC (as listed)29300-366Labeler and product segments. Claims need a package NDC.
Product NDC at billing width29300-0366Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
29300-366-052930003660529300036605500 TABLET, FILM COATED in 1 BOTTLE (29300-366-05)Marketed from Dec 1, 2024
29300-366-16293000366162930003661660 TABLET, FILM COATED in 1 BOTTLE (29300-366-16)Marketed from Dec 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Lacosamide
Generic name (nonproprietary)
lacosamide
Active ingredients
Lacosamide — 150 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
Unichem Pharmaceuticals (USA), Inc.NDC labeler code 29300
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 213109
Marketing start
Listing expires
DEA schedule
CV
Other FDA classes
Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers
Product ID 29300-366_d452fee5-4940-4740-8c4d-8024788eafc6SPL ID d452fee5-4940-4740-8c4d-8024788eafc6SPL set ID 7ed5cebe-470e-48a4-86ec-2ce79cc32688RxCUI 809987, 809992, 809996, 810000UNII 563KS2PQY5

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N429300036605 followed by a unit qualifier and the quantity

Package 29300-0366-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Lacosamide tablet is indicated for: Treatment of partial-onset seizures in patients 4 years of age and older ( 1.1 ) Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older. Additional pediatric use information is approved for UCB, Inc.'s VIMPAT ® (lacosamide) tablets. However, due to UCB, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide tablets are indicated as adjunctive therapy in t…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 29300-366

What is NDC 29300-366?
29300-366 is the product NDC for Lacosamide, Lacosamide 150 mg/1 tablet, film coated, listed with the FDA by Unichem Pharmaceuticals (USA), Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Lacosamide.
What is the active ingredient?
Lacosamide.
Who is the labeler?
Unichem Pharmaceuticals (USA), Inc., NDC labeler code 29300. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lacosamide?
146 other product NDCs are listed under this name. See all Lacosamide NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lacosamide NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
LacosamideLacosamide 50 mg/1TabletOralAvPAK50268-49150268-0491-10
LacosamideLacosamide 100 mg/1TabletOralAvPAK50268-49250268-0492-10
LacosamideLacosamide 50 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-468970518-4689-0070518-4689-0270518-4689-03
LacosamideLacosamide 10 mg/mLInjection, SolutionIntravenousGLENMARK PHARMACEUTICALS INC., USA68462-69768462-0697-30
LacosamideLacosamide 100 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-456270518-4562-00
LacosamideLacosamide 100 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-456170518-4561-0070518-4561-02
LacosamideLacosamide 10 mg/mLInjection, SolutionIntravenousAnthea Pharma Private Limited83854-00283854-0002-10
LacosamideLacosamide 50 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-450370518-4503-00
LacosamideLacosamide 200 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-450470518-4504-0070518-4504-0170518-4504-03
LacosamideLacosamide 100 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-450570518-4505-00

All 147 Lacosamide NDCs

Other NDCs under ANDA 213109

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213109
ProductStrengthForm · routeLabelerProduct NDC
LacosamideLacosamide 50 mg/1Tablet, Film coatedOralUnichem Pharmaceuticals (USA), Inc.29300-364
LacosamideLacosamide 100 mg/1Tablet, Film coatedOralUnichem Pharmaceuticals (USA), Inc.29300-365
LacosamideLacosamide 200 mg/1Tablet, Film coatedOralUnichem Pharmaceuticals (USA), Inc.29300-367

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in